Argenx
ARGX
#419
Rank
NZ$96.97 B
Marketcap
NZ$1,557
Share price
-1.62%
Change (1 day)
48.81%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company